Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2026 08:30 ET | Source: Conexeu Sciences Inc.

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

RENO, Nev., June 15, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a biotechnology company advancing tissue regeneration, today announced additions to...
June 08, 2026 08:30 ET | Source: Conexeu Sciences Inc.

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”) today announced progress in manufacturing scale up and standardized formulation...
June 03, 2026 08:30 ET | Source: Conexeu Sciences Inc.

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing...
May 27, 2026 10:36 ET | Source: Conexeu Sciences Inc.

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

RENO, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced the launch of a...
May 27, 2026 08:30 ET | Source: Conexeu Sciences Inc.

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

RENO, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced the launch of a preclinical...